Herbert Smith Freehills Kramer LLP advises leading life sciences companies across the product lifecycle, with notable strength in patent litigation (particularly in generic and biosimilar challenges), commercial disputes and corporate M&A. Alan Montgomery, a ‘standout’ specialist in cross-border M&A, investment and commercial agreements, co-leads the practice alongside Chris Parker KC, who focuses on international arbitrations. Sebastian Moore is noted for his patent litigation capability, running cases in the UK and coordinating cases across Europe. Emily Bottle and Priyanka Madan handle contentious and non-contentious IP and regulatory matters, while Kyriakos Fountoukakos strengthens the firm’s competition offering.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'In life sciences and healthcare, Alan Montgomery is a standout attorney.'
Key clients
- Gilead Sciences, Inc
- AbbVie, Inc
- Roche
- Genus plc
- Dr Reddy's Laboratories
- Biotage AB
- Johnson Matthey plc
- CSL Behring
- Sanofi
- Biogen
Work highlights
Advised Dr. Reddy's Laboratories Limited on its acquisition of Haleon plc's global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category outside of the United States.
Advised EQT Partners, a global investment firm, and its portfolio company Icon Group (Integrated Clinical Oncology Network) on its acquisition of the Pharmaxo Group.
Advised Millennium Pharmaceuticals, a US-headquartered biopharmaceutical company, and its licensee Johnson & Johnson in the pan-European enforcement of patents relating to Velcade (bortezomib), a first-in-class drug used to treat multiple myeloma and mantle cell lymphoma.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Alan Montgomery; Chris Parker
Other key lawyers
Sebastian Moore; Emily Bottle; Priyanka Madan; Kyriakos Fountoukakos; Jonathan Turnbull; Dylan Doran Kennett; Hannah Ambrose